Medical expert of the article
New publications
Preparations
Biotredin
Last reviewed: 10.08.2022
All iLive content is medically reviewed or fact checked to ensure as much factual accuracy as possible.
We have strict sourcing guidelines and only link to reputable media sites, academic research institutions and, whenever possible, medically peer reviewed studies. Note that the numbers in parentheses ([1], [2], etc.) are clickable links to these studies.
If you feel that any of our content is inaccurate, out-of-date, or otherwise questionable, please select it and press Ctrl + Enter.
Biotredin is a medicine used for alcoholism. It is a regulator of tissue metabolism that reduces alcohol cravings and increases intellectual function.
The L-threonine component undergoes a decomposition process under the influence of pyridoxine, forming acetaldehyde together with glycine. These elements help to stimulate retarding reactions, and with it the processes of reduction-oxidation, respiratory function and intracellular binding of the ATP component. [1]
Indications Biotredin
It is used in people with chronic alcoholism or alcohol abuse. In addition, it is used in the case of actualization of pathological craving for alcohol, which is combined with affective disorders (deterioration of mood, irritability and feelings of internal discomfort), as well as in the case of alcohol withdrawal. May be prescribed to identify and treat "latent craving" for alcohol.
In addition, it is used to increase concentration and intellectual activity.
Release form
The drug is released in the form of sublingual tablets - 30 pieces inside the contour plate. Inside the box there are 1 or 2 such plates.
Pharmacodynamics
The properties of the active elements of the drug contribute to the development of such effects:
- weakening of the stress having a psychoemotional nature;
- improvement of long- and short-term memory, and in addition to this concentration of attention;
- increased intellectual activity;
- stabilization and an increase in the indicators of internal acetaldehyde, which makes it possible to weaken alcohol withdrawal symptoms and cravings for alcohol consumption.
The therapeutic effect of the medication develops after 10-20 minutes from the moment of sublignal administration of the drug.
Pharmacokinetics
Pyridoxine together with L-threonine are fully metabolized with the formation of carbon dioxide and water. These substances do not accumulate inside the body.
Dosing and administration
The medication is used in the form of a sublingual tablet or as a powder, which is obtained by grinding an existing tablet.
To increase intellectual activity and improve attention, you need to take 1 tablet of the drug 2-3 times a day for a 3-10-day period. If necessary, this cycle can be repeated 3-4 times a year.
People who abuse alcohol, as well as suffering from alcoholism in the chronic phase, use 1-3 tablets per use, 2-3 times a day for a period of 4-5 days. If there is a need, such a course can be repeated 5-10 times a year.
During alcohol withdrawal for the 1st day, an adult should take 1-4 tablets, 3-4 times a day (the daily portion is thus within 3-16 tablets). On the 2nd day and in the future, the patient consumes 1-2 tablets per dose, 2-3 times a day (the daily dosage is 3-6 tablets), in the period of 3-4 weeks. The duration of the treatment cycle can be reduced to 10-14 days.
The drug reaches its maximum effect in the case of a combination with glycine (100 mg tablets), which is used sublingually 10-15 minutes before using Biotredin.
In remission, in order to determine the latent craving for alcohol, an adult needs to apply 2-3 tablets of drugs on an empty stomach. Dizziness, sweating, and redness on the face after a 10 to 20-minute stretch is a sign of such cravings. In such a case, a 5-10-day cycle of drug intake is prescribed (1-2 tablets 2-3 times a day) in combination with sublingual administration of 0.1 g of glycine (it is used 10-15 minutes before using Biotredin).
- Application for children
Forbidden for use in children under 15 years of age.
Use Biotredin during pregnancy
Biotredin can be administered to pregnant and breastfeeding women.
Contraindications
Among the contraindications:
- intoxication with alcohol;
- use together with medications that suppress the activity of the central nervous system (antipsychotics (antipsychotics), anxiolytics or antidepressants).
Side effects Biotredin
Taking Biotredin can cause the development of hyperhidrosis or dizziness.
Interactions with other drugs
The drug reduces the therapeutic activity of barbiturates with antidepressants, antipsychotics (neuroleptics), as well as other drugs that suppress the action of the central nervous system.
Storage conditions
Biotredin must be stored in a dark and dry place out of the reach of small children. Temperature values - no more than 25 ° С.
Shelf life
Biotredin can be used within a 36-month period from the date of sale of the medicinal substance.
Analogs
Analogs of the drug are Naltrexin, Antaxon, Lidevin, Disulfiram with Tetlong, Vivitrol and Medichronal with Teturam, and in addition to Kolme, Naltrex and Esperal.
Attention!
To simplify the perception of information, this instruction for use of the drug "Biotredin" translated and presented in a special form on the basis of the official instructions for medical use of the drug. Before use read the annotation that came directly to medicines.
Description provided for informational purposes and is not a guide to self-healing. The need for this drug, the purpose of the treatment regimen, methods and dose of the drug is determined solely by the attending physician. Self-medication is dangerous for your health.